Johnson and Johnson's vaccine is 66% effective against moderate to severe COVID-19

BioNTech-Pfizer mRNA vaccine largely effective against UK variant, Sera from 40 patients show

End of Trump’s ‘Muslim ban’ a relief to researchers, but obstacles remain

One-dose COVID-19 vaccine offers solid protection against severe disease